Safety Home Study Placement Decision Sample Clauses

Safety Home Study Placement Decision. (Approval) The decision to approve or deny placement under the BA Safety Home Study is the responsibility of the receiving state agency and must meet the receiving state agency’s current policies and procedures. If the BA Safety Home Study Placement Decision is a denial, proceed to Section C. Upon completion and approval of the BA Safety Home Study, the receiving state case manager will communicate the decision to approve the BA Safety Placement and reasons for that decision verbally to the sending state case manager by telephone within 30 minutes of the decision. Prior to or no later than the next business day after placement is made, the following must be completed: The receiving state case manager will fax or electronically scan a copy of the BA Safety Home Study, including attachments and appropriately dated signature authorizations, to the sending state case manager; The sending state case manager will initiate a call to the receiving state case manager to discuss the need for any immediate services and schedule a Family Team Meeting. See attached contact list for phone numbers. The sending state case manager will make arrangements for the scheduling, identification of, and notice to pertinent parties and document the Family Team Meeting in cooperation with the receiving state case manager prior to the expiration of the BA Immediate Safety Plan (TN) /Prevention Plan (KY). The BA Safety Placement of the non-custodial child with the relatives or “kin” is valid for a maximum of 3 business days from the date of approval excluding weekends and holidays as determined by Sending State. . A Family Team Meeting will be scheduled and held within 3 business days of the placement. Parents/ legal guardians, relatives and “kin” with temporary placement, TN DCS, and KY DCBS case managers and workers are expected to attend. However, the CPS worker that is not in the state where the conference is held may attend via telephone. Because Tennessee DCS policy requires a criminal record check and Kentucky DCBS policy provides only for a Kentucky state criminal record check before facilitating the voluntary placement of a non-custodial child with relatives or “kin”, TN DCS agrees to provide up to 15 NCIC III Purpose Code X criminal background checks annually on relatives and “kin” with whom children are to be placed under this Agreement. No information will be provided under this Agreement which would violate federal or state law or policy. All adult relatives or “kin” must...
Sample 1Sample 2
AutoNDA by SimpleDocs

Related to Safety Home Study Placement Decision

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • PROFESSIONAL DEVELOPMENT AND EDUCATIONAL IMPROVEMENT A. The Board agrees to implement the following:

  • Feasibility Study 4.3.1 The Feasibility Study shall identify any potential adverse system impacts that would result from the interconnection of the Generating Facility.

  • Professional Development Plan Professional Development Plan (PDP) refers to plans developed by faculty members addressing the criteria contained in Article 22 and Appendix G.

  • Professional Development Program (a) The parties agree to continue a Professional Development Program for the maintenance and development of the faculty members' professional competence and effectiveness. It is agreed that maintenance of currency of subject knowledge, the improvement of performance of faculty duties, and the maintenance and improvement of professional competence, including instructional skills, are the primary professional development activities of faculty members.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Synchronization, Commissioning and Commercial Operation 4.1.1 The Power Producer shall give at least thirty (30) days written notice to the SLDC and GUVNL, of the date on which it intends to synchronize the Power Project to the Grid System.

  • COUNTY’S QUALITY ASSURANCE PLAN The County or its agent will evaluate the Contractor’s performance under this Contract on not less than an annual basis. Such evaluation will include assessing the Contractor’s compliance with all Contract terms and conditions and performance standards. Contractor deficiencies which the County determines are severe or continuing and that may place performance of the Contract in jeopardy if not corrected will be reported to the Board of Supervisors. The report will include improvement/corrective action measures taken by the County and the Contractor. If improvement does not occur consistent with the corrective action measures, the County may terminate this Contract or impose other penalties as specified in this Contract.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

Time is Money Join Law Insider Premium to draft better contracts faster.